Liquidia CFO Michael Kaseta sells $539,354 in LQDA shares

On October 12, 2026, Liquidia Corp's CFO and COO, Michael Kaseta, sold 18,938 shares of the company's common stock for a total of $539,354. The shares were sold at $28.48 each and were part of a pre-arranged Rule 10b5-1 plan implemented on December 15, 2023. The primary reason for the sale was to settle taxes related to restricted stock units (RSUs) and performance stock units (PSUs) granted between January 2023 and January 2025.

Kaseta's stock, currently valued at $26.81, has dropped about 31% over the past six months. Conversely, InvestingPro analysts suggest that Liquidia remains undervalued, providing subscribers with 13 ProTips and additional insights. On October 9, 2026, Kaseta bought back 12,877 shares through the conversion of performance stock units (1:1 conversion), including 5,828 and 7,049 shares in separate transactions.

This sale brings Kaseta's total direct ownership of Liquidia Corp common stock to 340,148 shares, in addition to derivative securities worth 29,140 and 63,448 performance stock units. Recent news involving patent litigation with United Therapeutics has led to mixed analyst reactions, with some downgrading Liquidia's stock price, while others remain cautiously optimistic despite legal and regulatory challenges.